Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Chongquing Succeway made APIs in undeclared plant and faked records says ANSM

French regulators says Chongquing Succeway Pharmaceutical Co Ltd should recall APIs made at its plant in Chongquing after inspectors found evidence of record manipulation and an undeclared manufacturing area.

Site shut, 875 jobs cut: Endo to close US manufacturing facility

Endo International has announced it will close its manufacturing plant in Huntsville, Alabama and eliminate 875 positions.

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

update - comment from Unite

GSK says UK manufacturing cuts not Brexit related

GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.

The serialisation stragglers: industry concern for complacency

The US Food and Drug Administration’s (FDA) decision to delay serialisation regulations shows drug companies and contract manufacturers are still unprepared, say industry representatives.

WHO prequalifies Mylan's India unit to supply TB drug API

The WHO has prequalified Indian-based Mylan Laboratories Ltd to supply the tuberculosis drug ingredient protionamide.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...